Coverage
-
August 04, 2022
A California federal judge has granted lawyers with Robbins Geller Rudman & Dowd LLP more than $13.5 million in attorney fees along with final approval for a $54.2 million settlement for investors who alleged Puma Biotechnology Inc. misstated the effectiveness of a breast cancer treatment.
10 other articles on this case.
View all »